Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis

Trial Profile

d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis

Phase of Trial: Phase IV

Latest Information Update: 23 Aug 2018

At a glance

  • Drugs Gallium 68-DOTATATE (Primary) ; Fludeoxyglucose F-18
  • Indications Heart disorders; Sarcoidosis
  • Focus Diagnostic use
  • Most Recent Events

    • 23 Aug 2018 Last checked against ClinicalTrials.gov record.
    • 14 Aug 2018 Status changed from not yet recruiting to recruiting.
    • 14 Jun 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top